FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Edith Nutescu

Research Profile

Chemicals & Drugs

Disorders

Geographic Areas

United States

Procedures

Concepts & Ideas

Anatomy

Thrombosis

Living Beings

African Americans

Co-author Network

Publications

TOP 3
Edith A Nutescu
Oral anticoagulant therapies: Balancing the risks.
Edith A Nutescu
New approaches to reversing oral anticoagulant therapy Introduction.
Edith A Nutescu; Ann K Wittkowsky; Jack E Ansell; Allison Burnett; Geno J Merli; David A Garcia
Delivery of optimized inpatient anticoagulation therapy: consensus statement from the anticoagulation forum.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Edith Nutescu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Edith A Nutescu
Oral anticoagulant therapies: Balancing the risks.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2013;70(10 Suppl 1):S3-S11.
2013: Edith A Nutescu
New approaches to reversing oral anticoagulant therapy Introduction.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2013;70(10 Suppl 1):S1-2.
2013: Edith A Nutescu; Ann K Wittkowsky; Jack E Ansell; Allison Burnett; Geno J Merli; David A Garcia
Delivery of optimized inpatient anticoagulation therapy: consensus statement from the anticoagulation forum.
The Annals of pharmacotherapy 2013;47(5):714-24.
2013: Edith A Nutescu
Pharmacoeconomic implications of thromboprophylaxis with new oral anticoagulants after total hip or knee replacement in the USA.
Expert opinion on pharmacotherapy 2013;14(4):525-34.
2013: Edith A Nutescu; Glen T Schumock; Samir H Mody; Adriana Bautista; Brahim K Bookhart; William Galanter; Weihua Gao; Bruce L Lambert
Warfarin anticoagulation after total hip or total knee replacement: clinical and resource-utilization outcomes in a university-based antithrombosis clinic.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2013;70(5):423-30.
2012: Gregory Reardon; Jeff Schein; Chandrasekhar V Damaraju; Joyce Lamori; Edith A Nutescu; Naushira Pandya; Brahim K Bookhart
Use of warfarin therapy among residents who developed venous thromboembolism in the nursing home.
The American journal of geriatric pharmacotherapy 2012;10(6):361-72.
2012: Edith A Nutescu
Apixaban: a novel oral inhibitor of factor Xa.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2012;69(13):1113-26.
2012: Patrick Lefebvre; Edith A Nutescu; William H Olson; Jeff Schein; Brahim K Bookhart; Katherine Dea; Mei Sheng Duh; François Laliberté; Joyce LaMori; Scott Kaatz
All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries.
Journal of managed care pharmacy : JMCP 2012;18(5):363-74.
2012: Yong Liu; Edith A Nutescu; S R Patel; Nancy L Shapiro; H Takahashi; K Drozda; Hyun-Young Jeong; Larisa H Cavallari
Decreased warfarin clearance associated with the CYP2C9 R150H (*8) polymorphism.
Clinical pharmacology and therapeutics 2012;91(4):660-5.
2012: Larisa H Cavallari; Panos Deloukas; Keston Aquino-Michaels; Shitalben R Patel; Minoli Perera; Nancy L Shapiro; Gelson Taube; Marlos Viana; Mia Wadelius; Edith A Nutescu
Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans.
Pharmacogenetics and genomics 2012;22(2):152-8.
2012: Francis Vekeman; Edith A Nutescu; W H Olson; J Schein; Brahim K Bookhart; K Dea; Mei Sheng Duh; F Laliberté; J C LaMori; P Lefebvre
In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty.
Journal of medical economics 2012;15(4):644-53.
2011: Michael P Gulseth; William E Dager; John Fanikos; Sarah A Spinler; Ann K Wittkowsky; Edith A Nutescu
Dabigatran etexilate in clinical practice: confronting challenges to improve safety and effectiveness.
Pharmacotherapy 2011;31(12):1232-49.
2011: Edith A Nutescu; Glen T Schumock; Lisa K Sharp; Sacheeta Bathija; Ben S Gerber; Marian L Fitzgibbon
Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption.
Pharmacotherapy 2011;31(12):1161-74.
2011: Michelle Martin; Edith A Nutescu
Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgery.
Current medical research and opinion 2011;27(11):2123-31.
2011: Beth L Nordstrom; Edith A Nutescu; Jeff R Schein; Alan Fisher; Kathy H Fraeman; Sumesh Kachroo; Brahim K Bookhart
Warfarin prophylaxis in patients after total knee or hip arthroplasty--international normalized ratio patterns and venous thromboembolism.
Current medical research and opinion 2011;27(10):1973-85.
2011: Larisa H Cavallari; Taimour Y Langaee; Christopher Butler; Shitalben R Patel; Nancy L Shapiro; Marlos Viana; Nargis Wardak; Edith A Nutescu
Association of apolipoprotein E genotype with duration of time to achieve a stable warfarin dose in African-American patients.
Pharmacotherapy 2011;31(8):785-92.
2011: Nancy L Shapiro; Aimee B. Chevalier; Michelle A Kominiarek; Edith A Nutescu; Judith U Hibbard
Dosing and monitoring of low-molecular-weight heparin in high-risk pregnancy: single-center experience.
Pharmacotherapy 2011;31(7):678-85.
2011: Funda Tiryaki; Joel A Hennenfent; Annette M Karageanes; Larry J Koesterer; Bruce L Lambert; Edith A Nutescu; Glen T Schumock
Anticoagulation therapy for hospitalized patients: patterns of use, compliance with national guidelines, and performance on quality measures.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2011;68(13):1239-44.
2011: Michelle Martin; Sarah A Spinler; Edith A Nutescu
Emerging antiplatelet therapies in percutaneous coronary intervention: a focus on prasugrel.
Clinical therapeutics 2011;33(4):425-42.
2011: Edith A Nutescu; Ittiporn Chuatrisorn; Erika Hellenbart
Drug and dietary interactions of warfarin and novel oral anticoagulants: an update.
Journal of thrombosis and thrombolysis 2011;31(3):326-43.
2011: Larisa H Cavallari; Kathryn M Momary; Shitalben R Patel; Nancy L Shapiro; Edith A Nutescu; Marlos Viana
Pharmacogenomics of warfarin dose requirements in Hispanics.
Blood cells, molecules & diseases 2011;46(2):147-50.
2011: Edith A Nutescu
Characteristics of novel anticoagulants and potential economic implications.
The American journal of managed care 2011;17(1 Suppl):S27-32.
2011: Francis Vekeman; Joyce C LaMori; François Laliberté; Edith A Nutescu; Mei Sheng Duh; Brahim K Bookhart; Jeff Schein; Katherine Dea; William H Olson; Patrick Lefebvre
Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.
Journal of medical economics 2011;14(3):324-34.
2011: Joann Stubbings; Edith A Nutescu; Sandra F. Durley; Jerry L Bauman
Payment for clinical pharmacy services revisited.
Pharmacotherapy 2011;31(1):1-8.
2010: Ann K Wittkowsky; Sarah A Spinler; William Dager; Michael P Gulseth; Edith A Nutescu
Dosing guidelines, not protocols, for managing warfarin therapy.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2010;67(18):1554-6.
2010: Michelle Martin; Ann Kuchta; Edith A Nutescu
A clinician's guide to perioperative bridging for patients on oral anticoagulation.
Journal of pharmacy practice 2010;23(4):303-12.
2010: William Galanter; Mathew Thambi; Holly A. Rosencranz; Bobby Shah; Suzanne Falck; Fang-Ju Lin; Edith A Nutescu; Bruce L Lambert
Effects of clinical decision support on venous thromboembolism risk assessment, prophylaxis, and prevention at a university teaching hospital.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2010;67(15):1265-73.
2010: Maureen A Smythe; Edith A Nutescu; Ann K Wittkowsky
Changes in the USP heparin monograph and implications for clinicians.
Pharmacotherapy 2010;30(5):428-31.
2010: Edith A Nutescu
Anticoagulation management services: entering a new era.
Pharmacotherapy 2010;30(4):327-9.
2010: Larisa H Cavallari; Taimour Y Langaee; Kathryn M Momary; Nancy L Shapiro; Edith A Nutescu; W A Coty; Marlos Viana; S R Patel; Julie A Johnson
Genetic and clinical predictors of warfarin dose requirements in African Americans.
Clinical pharmacology and therapeutics 2010;87(4):459-64.
2010: Barbara J Zarowitz; Eric Tangalos; Allen Lefkovitz; Henry Bussey; Steven Deitelzweig; Edith A Nutescu; Terrence O'Shea; Barbara Resnick; Arthur Wheeler
Thrombotic risk and immobility in residents of long-term care facilities.
Journal of the American Medical Directors Association 2010;11(3):211-21.
2010: Anna Markel Vaysman; Edith A Nutescu
YM-150, a Factor Xa inhibitor for the prevention of venous thromboembolism and coronary artery disease.
Current opinion in investigational drugs (London, England : 2000) 2010;11(3):333-9.
2009: Paul P Dobesh; Ann K Wittkowsky; Zachary Stacy; William E Dager; Toby C Trujillo; Michael P Gulseth; Edith A Nutescu; Tom Vondracek
Key articles and guidelines in the treatment of venous thromboembolism.
Pharmacotherapy 2009;29(11):1385.
2009: Beth Nochowitz; Nancy L Shapiro; Edith A Nutescu; Larisa H Cavallari
Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population.
The Annals of pharmacotherapy 2009;43(7):1165-72.
2009: Edith A Nutescu; Sarah A Spinler; Ann K Wittkowsky; William E Dager
Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings.
The Annals of pharmacotherapy 2009;43(6):1064-83.
2009: Larisa H Cavallari; Jonathan L Aston; Kathryn M Momary; Nancy L Shapiro; Shitalben R Patel; Edith A Nutescu
Predictors of unstable anticoagulation in African Americans.
Journal of thrombosis and thrombolysis 2009;27(4):430-7.
2009: Paul P Dobesh; Ann K Wittkowsky; Zachary A Stacy; William E Dager; Stuart T. Haines; Larry M Lopez; Edith A Nutescu; Katherine W Phillips; Toby C Trujillo; Tom Vondracek
Key articles and guidelines for the prevention of venous thromboembolism.
Pharmacotherapy 2009;29(4):410-58.
2009: Toni L Ripley; Edith A Nutescu
Anticoagulation in patients with heart failure and normal sinus rhythm.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2009;66(2):134-41.
2009: Kathryn M Momary; Nancy L Shapiro; Larry D Brace; Stacy S Shord; Enzo Grossi; Marlos Viana; Cathy M Helgason; Edith A Nutescu; Larisa H Cavallari
Influence of cyclooxygenase-1 genotype on ex vivo aspirin response in patients at risk for stroke.
Cerebrovascular diseases (Basel, Switzerland) 2009;27(6):585-93.
2008: Ann K Wittkowsky; Edith A Nutescu; Emily Beth Devine
Compression stockings to prevent post-thrombotic syndrome: a role for anticoagulation clinics?
Journal of thrombosis and thrombolysis 2008;26(3):248-50.
2008: Andrew F Shorr; Edith A Nutescu; Eileen Farrelly; Ruslan Horblyuk; Laura E Happe; Meg Franklin
Postdischarge oral versus injectable anticoagulation following major orthopedic surgery.
The Annals of pharmacotherapy 2008;42(9):1222-8.
2008: Edith A Nutescu; Andrew F Shorr; Eileen Farrelly; Ruslan Horblyuk; Laura E Happe; Meg Franklin
Burden of deep vein thrombosis in the outpatient setting following major orthopedic surgery.
The Annals of pharmacotherapy 2008;42(9):1216-21.
2008: Michael P Gulseth; Jessica Michaud; Edith A Nutescu
Rivaroxaban: an oral direct inhibitor of factor Xa.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2008;65(16):1520-9.
2008: David A Garcia; Daniel M Witt; Elaine M Hylek; Ann K Wittkowsky; Edith A Nutescu; Alan Jacobson; Stephan Moll; Geno J Merli; Mark Crowther; Laura Earl; Richard C Becker; Lynn Oertel; Amir K Jaffer; Jack E Ansell
Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum.
The Annals of pharmacotherapy 2008;42(7):979-88.
2008: Edith A Nutescu; Nancy L Shapiro; Aimee B. Chevalier
New anticoagulant agents: direct thrombin inhibitors.
Cardiology clinics 2008;26(2):169-87, v-vi.
2008: Edith A Nutescu; Karen Steinmetz Pater
Economic evaluation of the use of enoxaparin in non-ST-elevation acute coronary syndrome.
Expert opinion on pharmacotherapy 2008;9(1):95-105.
2007: Kathryn M Momary; Nancy L Shapiro; Marlos Viana; Edith A Nutescu; Cathy M Helgason; Larisa H Cavallari
Factors influencing warfarin dose requirements in African-Americans.
Pharmacogenomics 2007;8(11):1535-44.
2007: Adam J Duhl; Michael J Paidas; Serdar H Ural; Ware Branch; Holly Casele; Joan Cox-Gill; Sheri Lynn Hamersley; Thomas M Hyers; Vern Katz; Randall Kuhlmann; Edith A Nutescu; James A Thorp; James L Zehnder
Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes.
American journal of obstetrics and gynecology 2007;197(5):457.e1-21.
2007: Edith A Nutescu
ASHP therapeutic position statement on antithrombotic therapy in chronic atrial fibrillation.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2007;64(21):2281-91.
2007: Karen M Grogan; Candice Wong; Edith A Nutescu; Stacy S Shord
Examining differences in weekly warfarin dose in patients with and without cancer.
Therapeutic drug monitoring 2007;29(5):638-43.
2007: Michael B Bottorff; Edith A Nutescu; Sarah A Spinler
Antiplatelet therapy in patients with unstable angina and non-ST-segment-elevation myocardial infarction: findings from the CRUSADE national quality improvement initiative.
Pharmacotherapy 2007;27(8):1145-62.
2007: Vikrant Vats; Edith A Nutescu; John C Theobald; Jeffrey E Wojtynek; Glen T Schumock
Survey of hospitals for guidelines, policies, and protocols for anticoagulants.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2007;64(11):1203-8.
2007: Edith A Nutescu
Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2007;64(11 Suppl 7):S5-13.
2007: Michelle A Kominiarek; S M Angelopoulos; Nancy L Shapiro; Laura Studee; Edith A Nutescu; Judith U Hibbard
Low-molecular-weight heparin in pregnancy: peripartum bleeding complications.
Journal of perinatology : official journal of the California Perinatal Association 2007;27(6):329-34.
2007: Edith A Nutescu; Roger S Klotz
Basic terminology in obtaining reimbursement for pharmacists' cognitive services.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2007;64(2):186-92.
2006: Edith A Nutescu
Easing the economic burden of acute coronary syndromes: cost-effectiveness of emerging therapies.
The American journal of managed care 2006;12(16 Suppl):S444-50.
2006: Edith A Nutescu
Anticoagulant agents are mainstay therapies in the prevention and treatment of arterial and venous thrombosis. Introduction.
The American journal of managed care 2006;12(16 Suppl):S427-9.
2006: Edith A Nutescu; Karen Pater
Drug evaluation: the directly activated Factor Xa inhibitor otamixaban.
IDrugs : the investigational drugs journal 2006;9(12):854-65.
2006: Ann K Wittkowsky; Edith A Nutescu; Juan Blackburn; Jennifer Mullins; Jennifer Hardman; Jessica Mitchell; Vikrant Vats
Outcomes of oral anticoagulant therapy managed by telephone vs in-office visits in an anticoagulation clinic setting.
Chest 2006;130(5):1385-9.
2006: Edith A Nutescu
Economic considerations in managing patients with chronic stable angina.
Journal of managed care pharmacy : JMCP 2006;12(8 Suppl):S17-21.
2006: Edith A Nutescu; Ann K Wittkowsky; Paul P Dobesh; David W Hawkins; William E Dager
Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: a case-based approach.
The Annals of pharmacotherapy 2006;40(9):1558-71.
2006: Ann K Wittkowsky; Jennifer Downing; Juan Blackburn; Edith A Nutescu
Warfarin-related outcomes in patients with antiphospholipid antibody syndrome managed in an anticoagulation clinic.
Thrombosis and haemostasis 2006;96(2):137-41.
2006: Edith A Nutescu; Nancy L Shapiro; Sonia Ibrahim; Patricia M West
Warfarin and its interactions with foods, herbs and other dietary supplements.
Expert opinion on drug safety 2006;5(3):433-51.
2006: Larisa H Cavallari; Cathy M Helgason; Larry D Brace; Marlos Viana; Edith A Nutescu
Sex difference in the antiplatelet effect of aspirin in patients with stroke.
The Annals of pharmacotherapy 2006;40(5):812-7.
2006: Sean D Sullivan; Louis Kwong; Edith A Nutescu
Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip fracture surgery.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2006;9(2):68-76.
2006: Harumi Takahashi; Grant R Wilkinson; Edith A Nutescu; Takashi Morita; Marylyn Ritchie; Maria Gabriella Scordo; Vittorio Pengo; Martina Barban; Roberto Padrini; Ichiro Ieiri; Kenji Otsubo; Toshitaka Kashima; Sosuke Kimura; Shinichi Kijima; Hirotoshi Echizen
Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans.
Pharmacogenetics and genomics 2006;16(2):101-10.
2006: Edith A Nutescu; Nancy L Shapiro; Aimee B. Chevalier
New anticoagulant agents: direct thrombin inhibitors.
Clinics in geriatric medicine 2006;22(1):33-56, viii.
2005: Edith A Nutescu; Hayley Y Park; Surrey M Walton; Juan C Blackburn; Jamie M Finley; Richard K Lewis; Glen T Schumock
Factors that influence prescribing within a therapeutic drug class.
Journal of evaluation in clinical practice 2005;11(4):357-65.
2005: Edith A Nutescu; Ann K Wittkowsky; William E Dager
Uncertain times for oral anticoagulation therapy.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2005;62(14):1449.
2005: Edith A Nutescu; Cathy M Helgason
Concomitant drug, dietary, and lifestyle issues in patients with atrial fibrillation receiving anticoagulation therapy for stroke prophylaxis.
Current treatment options in cardiovascular medicine 2005;7(3):241-50.
2005: Sarah A Spinler; Ann K Wittkowsky; Edith A Nutescu; Maureen A Smythe
Anticoagulation monitoring part 2: Unfractionated heparin and low-molecular-weight heparin.
The Annals of pharmacotherapy 2005;39(7-8):1275-85.
2005: Sarah A Spinler; Edith A Nutescu; Maureen A Smythe; Ann K Wittkowsky
Anticoagulation monitoring part 1: warfarin and parenteral direct thrombin inhibitors.
The Annals of pharmacotherapy 2005;39(6):1049-55.
2005: Edith A Nutescu; Nancy L Shapiro; Aimee B. Chevalier; Alpesh N Amin
A pharmacologic overview of current and emerging anticoagulants.
Cleveland Clinic journal of medicine 2005;72 Suppl 1():S2-6.
2005: Stuart T. Haines; Edith A Nutescu
Current and emerging treatment options for venous thrombosis: a case discussion.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2005;62(6):593-605.
2005: Ann K Wittkowsky; Colleen M Sekreta; Edith A Nutescu; Jack Ansell
Barriers to patient self-testing of prothrombin time: national survey of anticoagulation practitioners.
Pharmacotherapy 2005;25(2):265-9.
2004: Edith A Nutescu
Point of care monitors for oral anticoagulant therapy.
Seminars in thrombosis and hemostasis 2004;30(6):697-702.
2004: Rachel A Bongiorno; Edith A Nutescu
Generic warfarin: implications for clinical practice and perceptions of anticoagulation providers.
Seminars in thrombosis and hemostasis 2004;30(6):619-26.
2004: Edith A Nutescu
Emerging options in the treatment of venous thromboembolism.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2004;61(23 Suppl 7):S12-7.
2004: Edith A Nutescu
Strategies for cost-effective prevention and treatment of venous thromboembolism. Introduction.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2004;61(23 Suppl 7):S3-4.
2004: Edith A Nutescu; Cathy M Helgason; Joan Briller; Dorie W Schwertz
New blood thinner offers first potential alternative in 50 years: ximelagatran.
The Journal of cardiovascular nursing 2004;19(6):374-83.
2004: William E Dager; Thomas G Vondracek; Bruce A McIntosh; Edith A Nutescu
Ximelagatran: an oral direct thrombin inhibitor.
The Annals of pharmacotherapy 2004;38(11):1881-97.
2004: Edith A Nutescu; Sarah A Spinler; William E Dager; Henry I Bussey
Transitioning from traditional to novel anticoagulants: the impact of oral direct thrombin inhibitors on anticoagulation management.
Pharmacotherapy 2004;24(10 Pt 2):199S-202S.
2004: Glen T Schumock; Juan C Blackburn; Edith A Nutescu; Surrey M Walton; Jamie M Finley; Richard K Lewis
Impact of prescribing guidelines for inpatient anticoagulation.
The Annals of pharmacotherapy 2004;38(10):1570-5.
2004: Edith A Nutescu; Alex C Spyropoulos; Kerry W Cranmer
Oral anticoagulation: preparing for change.
Journal of the American Medical Directors Association 2004;5(5 Suppl 1):2-11.
2004: Edith A Nutescu; A Simon Pickard; Juan C Blackburn; Ann K Wittkowsky; Jack Ansell; Glen T Schumock
Impact of oral direct thrombin inhibitors on anticoagulation clinics.
Pharmacotherapy 2004;24(9):1204-12.
2004: Edith A Nutescu; Jerry L Bauman
Shifting paradigms in oral anticoagulation management.
Journal of cardiovascular pharmacology and therapeutics 2004;9(3):149-50.
2004: Edith A Nutescu; Manider Singh-Khalsa
Treatment of venous thromboembolism: challenging the unfractionated heparin standard.
Pharmacotherapy 2004;24(8 Pt 2):127S-131S.
2004: William E Dager; Judith C Andersen; Edith A Nutescu
Special considerations with fondaparinux therapy: heparin-induced thrombocytopenia and wound healing.
Pharmacotherapy 2004;24(7 Pt 2):88S-94S.
2004: Edith A Nutescu; Cathy M Helgason
Evolving concepts in the treatment of venous thromboembolism: the role of factor Xa inhibitors.
Pharmacotherapy 2004;24(7 Pt 2):82S-87S.
2004: Ann K Wittkowsky; Kelly S Whitely; Emily Beth Devine; Edith A Nutescu
Effect of age on international normalized ratio at the time of major bleeding in patients treated with warfarin.
Pharmacotherapy 2004;24(5):600-5.
2004: Glen T Schumock; Surrey M Walton; Hayley Y Park; Edith A Nutescu; Juan C Blackburn; Jamie M Finley; Richard K Lewis
Factors that influence prescribing decisions.
The Annals of pharmacotherapy 2004;38(4):557-62.
2004: Cathy M Helgason; Mary Anthu Do; Edith A Nutescu
Warfarin in patients with stroke and reasons for discontinuation.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2004;13(2):70-3.
2004: Edith A Nutescu; Ann K Wittkowsky
Direct thrombin inhibitors for anticoagulation.
The Annals of pharmacotherapy 2004;38(1):99-109.
2003: Edith A Nutescu; Nancy L Shapiro; Helen Feinstein; Christina W Rivers
Tinzaparin: considerations for use in clinical practice.
The Annals of pharmacotherapy 2003;37(12):1831-40.
2003: Edith A Nutescu; Nancy L Shapiro
Ezetimibe: a selective cholesterol absorption inhibitor.
Pharmacotherapy 2003;23(11):1463-74.
2003: Edith A Nutescu
Antithrombotic therapy for the treatment of venous thromboembolism.
The American journal of managed care 2003;9(5 Suppl):S103-14; quiz S115-20.
2003: Edith A Nutescu
The future of anticoagulation clinics.
Journal of thrombosis and thrombolysis 2003;16(1-2):61-3.
2003: Paul C Peters; Edith A Nutescu; Judith C Andersen
Wound pharmacobiology.
Orthopedics 2003;26(8 Suppl):s837-42.
2003: Edith A Nutescu; Richard K Lewis; Jamie M Finley; Glen T Schumock
Hospital guidelines for use of low-molecular-weight heparins.
The Annals of pharmacotherapy 2003;37(7-8):1072-81.
2002: Edith A Nutescu; Eric Racine
Traditional versus modern anticoagulant strategies: summary of the literature.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2002;59(20 Suppl 6):S7-14.
2002: Malcolm Fraser; Edith A Nutescu; Laurie G Jacobs
Anticoagulation in long-term care: the state of the art.
Journal of the American Medical Directors Association 2002;3(4 Suppl):H17-20.
2002: Glen T Schumock; Edith A Nutescu; Surrey M Walton; Bhakti V Arondekar; Richard K Lewis
Survey of hospital policies regarding low-molecular-weight heparins.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2002;59(6):534-8.
2001: B A Duplaga; C W Rivers; Edith A Nutescu
Dosing and monitoring of low-molecular-weight heparins in special populations.
Pharmacotherapy 2001;21(2):218-34.
1999: K L Shek; Lingtak-Neander Chan; Edith A Nutescu
Warfarin-acetaminophen drug interaction revisited.
Pharmacotherapy 1999;19(10):1153-8.
1998: Edith A Nutescu; C Hunt; J Teeters
Multidisciplinary approach to improving allergy documentation.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1998;55(4):364-8.